Pharmacogenetic dosing by UGT1A1 genotype as first-line therapy for advanced small-bowel adenocarcinoma: A North Central Cancer Treatment Group (NCCTG) trial
- Citation:
- J Clin Oncol vol 30 (4 suppl) abstr 314
- Meeting Instance:
- ASCO 2012
- Year:
- 2012
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2536
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- R. R. Mcwilliams M. R. Mahoney B. T. Marchello A. Jatoi K. D. Krewer M. M. Ames D. J. Schneider G. R. Seeger R. B. Mowat S. R. Alberts M. P. Goetz
- Networks:
- Study
- NCCTG-N0543
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: